LIGANDS AND ACCESSORY FACTORS IN CD4+ T CELL PRIMING
Project Number5R01AI026810-03
Contact PI/Project LeaderJANEWAY, CHARLES A
Awardee OrganizationYALE UNIVERSITY
Description
Abstract Text
The most critical event in the induction of most-immune responses
is the activation of a resting CD4+ T cell by antigen. This step
in the immune response appears to require not only the presentation
of sufficient ligand for the T cell receptor but accessory signals
as well. This step leads to the generation of both memory and
effector T cells. This step in immune responses is very difficult
to analyze in detail, as it has not been mimicked effectively in
vitro, and is usually studied by in vivo priming with antigen.
The goal of the present studies is to use anti-T cell receptor
antibody as a substitute for antigen, and to characterize priming
of T cells using a variety of detection systems, some of which may
not require T cell proliferation. Four different types of
information are being sought: First, can we define cell surface
molecules, physical changes or intracellular events that define
different stages of differentiation in CD4+ T cells, allowing us
to place a given cell in a given activation state, and also
allowing the measurement of transitions from one stats to another?
Second, what are the requirements, both in terms of ligand and in
terms of accessory cells or molecules derived from accessory cells,
needed to drive a resting CD4+ T cell to memory or effector cells?
Third, how do requirements for priming of D4+ T cells to become
helper or inflammatory T cells differ? Finally, how do the
activation requirements of T cells in different states of
differentiation differ from one another, and what is the mechanism
of this change?
To carry out these studies, we will use monoclonal antibodies to
the T cell receptor bound to cells or to plastic, or in soluble
form, to stimulate resting or activated CD4+ T cells or cloned T
cell lines representing different states of activation and
different functional phenotypes, and compare activation
requirements. Such assays will be used to identify and purify
accessory cell molecules that contribute to in vitro priming.
Monoclonal antibodies will be raised against these accessory cell
factors and against cell surface molecules on cells in different
states of activation so that we can accurately define activation
state.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
043207562
UEI
FL6GV84CKN57
Project Start Date
01-January-1989
Project End Date
31-December-1993
Budget Start Date
01-January-1991
Budget End Date
31-December-1991
Project Funding Information for 1991
Total Funding
$161,865
Direct Costs
$96,348
Indirect Costs
$65,517
Year
Funding IC
FY Total Cost by IC
1991
National Institute of Allergy and Infectious Diseases
$161,865
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI026810-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI026810-03
Patents
No Patents information available for 5R01AI026810-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI026810-03
Clinical Studies
No Clinical Studies information available for 5R01AI026810-03
News and More
Related News Releases
No news release information available for 5R01AI026810-03
History
No Historical information available for 5R01AI026810-03
Similar Projects
No Similar Projects information available for 5R01AI026810-03